Dong XD - Search Results

1

RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.

Dong XD, Lu Q, Li YD, Cai CY, Teng QX, Lei ZN, Wei ZH, Yin F, Zeng L, Chen ZS. Dong XD, et al. J Transl Int Med. 2024 Jul 27;12(3):288-298. doi: 10.2478/jtim-2024-0011. eCollection 2024 Jun. J Transl Int Med. 2024. PMID: 39081282 Free PMC article.

2

Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer Cells.

Cui Q, Cai CY, Wang JQ, Zhang S, Gupta P, Ji N, Yang Y, Dong X, Yang DH, Chen ZS. Cui Q, et al. Int J Mol Sci. 2019 Aug 22;20(17):4095. doi: 10.3390/ijms20174095. Int J Mol Sci. 2019. PMID: 31443367 Free PMC article.

3

Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells.

Wang J, Wang JQ, Cai CY, Cui Q, Yang Y, Wu ZX, Dong X, Zeng L, Zhao L, Yang DH, Chen ZS. Wang J, et al. Front Oncol. 2020 Feb 27;10:228. doi: 10.3389/fonc.2020.00228. eCollection 2020. Front Oncol. 2020. PMID: 32175279 Free PMC article.

4

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells.

Feng W, Zhang M, Wu ZX, Wang JQ, Dong XD, Yang Y, Teng QX, Chen XY, Cui Q, Yang DH. Feng W, et al. Among authors: dong xd. Front Oncol. 2020 Jun 25;10:955. doi: 10.3389/fonc.2020.00955. eCollection 2020. Front Oncol. 2020. PMID: 32670878 Free PMC article.

5

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells.

Li YD, Mao Y, Dong XD, Lei ZN, Yang Y, Lin L, Ashby CR Jr, Yang DH, Fan YF, Chen ZS. Li YD, et al. Among authors: dong xd. Front Oncol. 2020 Jun 26;10:932. doi: 10.3389/fonc.2020.00932. eCollection 2020. Front Oncol. 2020. PMID: 32676451 Free PMC article.

6

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance.

Zhang M, Chen XY, Dong XD, Wang JQ, Feng W, Teng QX, Cui Q, Li J, Li XQ, Chen ZS. Zhang M, et al. Among authors: dong xd. Front Oncol. 2020 Jul 23;10:1219. doi: 10.3389/fonc.2020.01219. eCollection 2020. Front Oncol. 2020. PMID: 32793491 Free PMC article.

7

Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells.

Dong XD, Zhang M, Ma X, Wang JQ, Lei ZN, Teng QX, Li YD, Lin L, Feng W, Chen ZS. Dong XD, et al. Front Cell Dev Biol. 2020 Aug 27;8:865. doi: 10.3389/fcell.2020.00865. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32984343 Free PMC article.

8

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells.

Dong XD, Zhang M, Cai CY, Teng QX, Wang JQ, Fu YG, Cui Q, Patel K, Wang DT, Chen ZS. Dong XD, et al. Front Pharmacol. 2022 Feb 23;13:843829. doi: 10.3389/fphar.2022.843829. eCollection 2022. Front Pharmacol. 2022. PMID: 35281897 Free PMC article.

9

Design, synthesis, and biological evaluation of phenylurea indole derivatives as ABCG2 inhibitors.

Ye GJ, Cai CY, Dong XD, Wu ZX, Teng QX, Wang JQ, Chen ZS, Wang B. Ye GJ, et al. Among authors: dong xd. Bioorg Chem. 2023 Jun;135:106481. doi: 10.1016/j.bioorg.2023.106481. Epub 2023 Mar 17. Bioorg Chem. 2023. PMID: 36966672

10

N,N-dimethylacetamide targets neuroinflammation in Alzheimer's disease in in-vitro and ex-vivo models.

Wei ZH, Koya J, Acharekar N, Trejos J, Dong XD, Schanne FA, Ashby CR Jr, Reznik SE. Wei ZH, et al. Among authors: dong xd. Sci Rep. 2023 May 1;13(1):7077. doi: 10.1038/s41598-023-34355-w. Sci Rep. 2023. PMID: 37127686 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters